SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

IonQ, Inc. develops and manufactures quantum computers. The firm specializes in quantum computing and quantum information processing. The company was founded by Christopher Monroe and Jung Sang Kim in 2015 and is headquartered in College Park, MD.

IonQ Inc

IonQs better-than-expected quarterly results and raised full-year revenue outlook are driving attention, with traders also highlighting its growing backlog and NVIDIA research-center partnership. Bulls see evidence of commercial momentum and quantum-sector strength, while skeptics remain concerned about dilution, cash burn, and whether growth will translate into durable returns.

POET Technologies, Inc. engages in the designing, developing, manufacturing and sale of opto-electronic solutions for the sensing, data communications and telecommunications markets. It developed POET Optical Interposer platform, which allows the integration of electronic and photonic devices into a single multi-chip module. The company was founded on November 14, 1985 and is headquartered in Toronto, Canada.

POET Technologies Inc

A Foxconn Tech Day display identifying a POET optical engine has renewed attention to the companys existing FIT collaboration, alongside the appointment of a new CFO. Traders see the visibility as validation and hope for commercial orders, while skeptics note it does not confirm new purchase orders or scaled shipments and want proof of revenue growth.

Intuitive Machines, Inc. is a space exploration, infrastructure, and services company, which engages in contributing to the establishment of cislunar infrastructure and helping to develop cislunar and deep space commerce. It offers space products and services. The company was founded by Stephen J. Altemus, Kam Ghaffarian, and Timothy P. Crain in 2013 and is headquartered in Houston, TX.

Intuitive Machines Inc - Ordinary Shares - Class A

Intuitive Machines Inc

LUNRs sharp rebound after a steep selloff has traders pointing to the dismissal of the CLPS 2 bid protest, anticipated NASA contract news, and possible short covering. Some see a recovery in space stocks, while others warn the bounce may be temporary and question whether a contract award is imminent.

Xeris Biopharma Holdings, Inc. is a biopharmaceutical company, which engages in developing and commercializing products across a range of therapies. Its products include Gvoke, Keveyis, and Recorlev. Gvoke is a ready-to-use liquid glucagon for the treatment of severe hypoglycemia. Keveyis is the therapy approved in the United States to treat hyperkalemic, hypokalemic, and related variants of primary periodic paralysis (PPP). Recorlev is a cortisol synthesis inhibitor approved for the treatment of endogenous hypercortisolemia in adult patients with Cushing’s syndrome. The company was founded by Steven Prestrelski in 2005 and is headquartered in Chicago, IL.

Xeris Biopharma Holdings Inc

Strong Q3 results and raised revenue outlook, alongside managements view that Recorlev could reach blockbuster-scale sales sooner than previously expected, are driving XERSs sharp rally. Traders are celebrating the growth story and analyst upgrades, while takeover speculation remains unconfirmed and some expect a pullback after the run.

DraftKings, Inc. is a digital sports entertainment and gaming company, which engages in the provision of online sports betting, online casino, daily fantasy sports product offerings, DraftKings Marketplace, retail sportsbook, media, and other consumer product offerings. The company was founded by Jason D. Robins, Matthew Kalish, and Paul Liberman on December 31, 2011 and is headquartered in Boston, MA.

DraftKings Inc. - Ordinary Shares - Class A

DraftKings Inc

DraftKings shares plunged after a Q3 earnings and revenue miss and a sharply reduced full-year outlook, with the company attributing much of the cut to heavy investment in its Predictions business. Traders are debating whether that spending can build a new growth engine or will weigh on profitability amid competition, while also criticizing management and the weaker guidance.

Firefly Aerospace, Inc. engages in the design and manufacture of space launch vehicles. The company was founded by Thomas E. Markusic, Mark Watt, and Max Polyakov in January 2017 and is headquartered in Leander, TX.

Firefly Aerospace Inc.

Fireflys multi-year agreement to supply engines, license propulsion technology and provide engineering support for AST SpaceMobiles planned heavy-lift rocket is driving attention. Traders largely view the deal as validation of Fireflys engine business and a boost to its outlook, while some question the stock-based payment terms and execution risks; the sharp rally has also prompted short-squeeze speculation.

AppLovin Corp. engages in the development and operation of a mobile marketing platform. It offers AppDiscovery, MAX, Adjust, and SparkLabs. Its software-based platform caters to mobile application developers to improve the marketing and monetization of applications. The company was founded by Andrew Karam, John Krystynak, and Adam Foroughi in 2011 and is headquartered in Palo Alto, CA.

Applovin Corp - Ordinary Shares - Class A

Applovin Corp

AppLovins stronger-than-expected quarterly results, upbeat outlook, and expanded share-repurchase authorization have driven a sharp post-earnings rally, with traders crediting momentum in its AI-powered advertising business. Bulls see a recovery and potential for further gains, while skeptics warn the move is overextended and may draw profit-taking.

Joby Aviation, Inc. is a transportation company, which engages in developing an all-electric, vertical take-off and landing aircraft that intends to operate as a commercial passenger aircraft. The company was founded by Bevirt Joebenn in 2009 and is headquartered in Santa Cruz, CA.

Joby Aviation Inc

A quarterly revenue beat, higher full-year outlook and progress in the final FAA certification stage have fueled renewed attention on JOBY, alongside updates on manufacturing and defense business. Bulls see a path toward commercialization and speculate about short covering, while skeptics stress that certification remains incomplete and cash burn and dilution risks persist.

Infleqtion, Inc. engages in delivering neutral atom solutions for quantum computing, networking, sensing, and security. Its products are categorized into computing, sensing, and cores. The company was founded on February 7, 2007, and is headquartered in Louisville, CO.

Infleqtion Inc. - Ordinary Shares - Class A

Infleqtion Inc.

INFQ is rebounding alongside quantum stocks after Intels move to acquire a quantum company, which traders see as validation for the sector. The community also cites CEO Matt Kinsellas media appearance and speculates about short covering, though some view the rise as a bounce from the recent selloff rather than a company-specific catalyst.

TeraWulf, Inc. owns and operates fully integrated environmentally clean bitcoin mining facilities in the United States. It will generate domestically produced bitcoin powered by nuclear, hydro, and solar energy. It operates through the Digital Asset Mining and HPC Leasing segments. The company was founded by Paul B. Prager and Nazar M. Khan on February 8, 2021 and is headquartered in Easton, MD.

TeraWulf Inc

TeraWulfs stronger-than-expected Q3 results and Google credit support for financing tied to its Anthropic data-center lease, alongside a Fluor construction agreement, have focused attention on its AI/HPC buildout. Bulls see the financing support as reducing risk, while skeptics point to sector weakness, execution and construction risks, and regulatory uncertainty.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Micro Cap Profusa Navigates European Regulatory Hurdles to Advance Oxygen Monitoring Tech

Profusa received ISO 13485 certification from GMED, advancing its Lumee Oxygen Platform toward CE marking in the European Union.read more...

Refinery Restart, $42 Million Greenland War Chest and Big $20 Target: These Stocks Have News

The market is watching a diverse group of companies as catalysts converge. NeOnc Technologies Holdings (NASDAQ:NTHI) attracted fresh Wall Street coverage around its brain-cancer pipeline; Profusa (NASDAQ:PFSA) is moving closer to a potential European regulatory milestone; Sky Quarry (NASDAQ:SKYQ) restarted Nevada's Eagle Springs Refinery; Glucotrack (NASDAQ:GCTK) is turning its Lōkahi asset-discovery platform toward external revenue; while Greenland Mines Ltd. (NASDAQ:GRML) and Greenland Energy Company (NASDAQ:GLND) are advancing separate projects in Greenland.

Wall Street Lights the Fuse and These Stocks Just Delivered Market-Moving News

The markets are producing a striking mix of catalysts, with NeOnc (NASDAQ:NTHI), Kraig Biocraft Laboratories (OTCQB:KBLB), Profusa (NASDAQ:PFSA), Sky Quarry (NASDAQ: SKYQ), Glucotrack (NASDAQ:GCTK) and Greenland Mines (NASDAQ:GRML) all generating fresh developments.

Profusa Clears a Critical Regulatory Hurdle and Now the Clock Is Ticking

Profusa (NASDAQ:PFSA) is moving closer to a potentially important commercial inflection point for its Lumee Oxygen Platform after receiving a positive decision from GMED regarding certification of its quality management system to ISO 13485, the international quality-management standard for medical devices.

12 Health Care Stocks Moving In Thursday's Pre-Market Session

Gainers

Profusa (NASDAQ:PFSA) stock increased by 112.5% to $4.36 during Thursday's pre-market session. The company's market cap stands at $1.2 million.
GlucoTrack (NASDAQ:GCTK) stock rose 96.55% to $3.99. Theread more...

12 Health Care Stocks Moving In Thursday's After-Market Session

Gainers

Werewolf Therapeutics (NASDAQ:HOWL) stock moved upwards by 77.1% to $0.76 during Thursday's after-market session. The company's market cap stands at $19.8 million.
Profusa (NASDAQ:PFSA) stock roseread more...

Profusa Stock Dips After Hours As Whopping 506% Rally Cools: Here Is Why PFSA Is Trending

Profusa shares fell 35.04% after hours Tuesday following a massive 506.62% intraday surge to $27.48 amid volatile trading.read more...

Profusa, Baidu, Amylyx Pharmaceuticals, FreeCast and Klarna Group: Why These 5 Stocks Are on Investors' Radars Today

PFSA, BIDU, AMLX, CAST, KLAR were among the stocks seen trending on Tuesday, Aug. 18, 2026.read more...

These Stocks are Keeping the Heat Up

The market is once again rewarding companies that can produce a combination of real operating progress, identifiable catalysts and a credible path to growth, including NeOnc (NASDAQ:NTHI), Profusa (NASDAQ:PFSA), CorMedix (NASDAQ:CRMD), IP Strategy (NASDAQ:IPST), Haemonetics (NYSE:HAE), Heartflow (NASDAQ:HTFL), and FreeCast (NASDAQ:CAST).

This Biotech Stock Crashed 28% Today After Announcing Second Reverse Share Split This Year

Equity

Profusa is set to implement a 1-for-25 reverse stock split on July 7.

Profusa, Inc. engages in biofeedback for chronic disease management and healthy living services. The company is founded by Natalie Wisniewski and Bill McMillan and is headquartered in Berkeley, CA.

Profusa Inc.

Bearish Sentiment

<ul class="summary-bullets"><li>Profusa expects its outstanding common shares to decline from around 13.2 million to about 530,000 after the consolidation becomes effective.</li><li>The move comes less than five months after the company completed a 1-for-75 reverse stock split.</li><li>PFSA shares fell below $1 on April 10 and have failed to surpass the level since.</li></ul>Shares of Profusa (PFSA) hit a record low on Thursday, crashing 28% after the biotech company announced its second reverse stock split of the year.Profusa said it will implement a 1-for-25 reverse stock split, effective July 7, 2026. The company's shares will continue trading under the same ticker.Following the action, Profusa expects its outstanding common shares to decline from around 13.2 million to about 530,000, while the number of authorized shares will remain unchanged at 601 million.Last month, Profusa’s shareholders voted to effect one or more reverse splits over the course of the next two years at a ratio of between 1-for-5 and 1-for-200. The final ratio would be determined by the board of directors.<h2 class="st-heading-2">PFSA’s February Consolidation</h2>The move comes less than five months after Profusa completed a 1-for-75 reverse stock split. PFSA shares fell below $1 on April 10 and have since failed to breach the crucial level.&nbsp;Nasdaq requires listed companies to maintain a minimum bid price of $1. If a stock remains below that level for an extended period, it risks being delisted from the exchange.<h2 class="st-heading-2">PFSA’s Pursuit Of Recurring Revenue Opportunities</h2>The company has been looking to expand its diagnostic capabilities. In April, it <a href="https://stocktwits.com/news-articles/markets/equity/why-did-pfsa-stock-surge-in-pre-market-today/cZJ4KekRIov">announced</a> plans to acquire the PanOmics molecular diagnostics platform from BioInsights for about $30 million.Profusa said the acquisition would complement its real-time biosensing technology and support new applications, including pancreatic cancer monitoring and other recurring-revenue opportunities.<h2 class="st-heading-2">Retail’s Take On PFSA</h2>Retail sentiment surrounding <a href="https://stocktwits.com/symbol/PFSA">PFSA</a> flipped to ‘bullish’ from ‘bearish’ a day earlier, while message volumes surged by over 400%.PFSA shares have fallen around 70% over the past month.Also read: <a href="https://stocktwits.com/news-articles/markets/equity/lcid-stock-falls-lucid-reports-q2-deliveries-cfo-change-weak/cZmeoRrR7Sw">LCID Stock In Spotlight Today Amid Leadership Transition – Q2 Deliveries Come In Weaker Than Expected</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

In this photo illustration, a chart depicting stock market crash, is displayed on a mobile phone screen in Ankara, Turkiye on August 5, 2024. (Photo by Osmancan Gurdogan/Anadolu via Getty Images)

Up more than 1% 

Flat to up 1%

Flat to down 1%

Down more than 1%

What do you think the S&amp;P 500&#39;s ($SPY) return will be next week?

Current Price	$0.5373
Prev Close	$0.5698
Open	$0.5278
Dividend Yield	0.00%
50-Day Moving Average	$1.73
Beta	1.08
Avg. Volume	2.53M
PE Ratio	0.00

52-Week High	$1,593.75
52-Week Low	$0.5395
Market Capitalization	$345,098.00
EPS (Annual)	-$10,700.78
Price to Book	-0.00
Revenue Per Employee	N/A

Feed

News

Sentiment

Fundamentals

Info

PFSA Fundamentals